Absci's Lower Per-Share Loss: Efficiency or Temporary Shift?

Friday, Nov 14, 2025 12:00 am ET1min read

Absci Corporation reported a net loss of $28.71 million for Q3 2025, with a slight improvement in basic loss per share from continuing operations compared to the previous year. This suggests some operational efficiency, but the company's persistent losses and limited revenue remain a challenge. Upcoming clinical trial data and adequate funding are crucial for investors.

Absci's Lower Per-Share Loss: Efficiency or Temporary Shift?

Comments



Add a public comment...
No comments

No comments yet